"As the situation of pandemic is still continuing, the extent to which the same will impact Company's future financial results is currently uncertain and will depend on further developments," it said.
At 10:27 AM, the stock was trading 3.88 per cent lower as compared to 0.8 per cent gain in the S&P BSE Sensex.
Nirmal Bang maintained 'SELL' on the stock but raised its target price to Rs 18,659 from Rs 18,189 earlier.
"Shree Cements has reported decent set of numbers for 1QFY21. Ebitda at Rs 700 crore was 3.4 per cent higher than our estimate but various operating parameters were lower than expectations. Revenue at Rs 2,325 crore declined by 23 per cent YoY as volume declined by 18.6 per cent YoY whereas realization declined by 5.9 per cent YoY," the brokerage said.
"We believe that as the economy returns to normalcy from the Covid shock, the current pent-up demand from the rural segment will subside. Higher pricing is also likely to fall as supply constraints reduce and monsoon impact on demand kicks in. The stock is currently trading at elevated multiples of 22x FY22E EV/EBITDA and hence we would wait for a correction to review our rating on the stock," it said.
Kotak Securities said Shree Cement's Q1 performance was 'subpar' but that it was too early to extrapolate.
"SRCM’s 1QFY21 Ebitda was weaker than our estimates led by lower realizations. Volumes outperformed industry with 19 per cent yoy decline; however, realization was weaker than peers with a decline of 6 per cent yoy. Costs, too, saw a sequential increase versus a decline by most peers. We think it is too early to be concerned on SRCM’s ability to retain its cost and margin leadership position; nonetheless, margin of safety is low given premium valuations. Maintain SELL," it said.
Analysts at Motilal Oswal said,"While we keep our estimates largely unchanged, we see challenges related to near-term margins for SRCM. These pertain to the hike in cost, but decline in price in its operating regions. The balance sheet should, however, strengthen further on limited capex under execution. We maintain Neutral as the current valuation (16.8x FY22E EV/EBITDA) does not offer any upside.".
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.